Elucirem

Active Ingredient(s): Gadopiclenol
FDA Approved: * September 21, 2022
Pharm Company: * GUERBET
Category: Diagnostic Aid
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Elucirem 485.1 mg/ml Intravenous Injection
NDC: 67684-4230
Labeler:
Guerbet LLC
Elucirem 485.1 mg/ml Intravenous Injection
NDC: 67684-4231
Labeler:
Guerbet LLC
Elucirem 485.1 mg/ml Intravenous Injection
NDC: 67684-4232
Labeler:
Guerbet LLC
Elucirem 485.1 mg/ml Intravenous Injection
NDC: 67684-4233
Labeler:
Guerbet LLC
Elucirem 485.1 mg/ml Intravenous Injection
NDC: 67684-4240
Labeler:
Guerbet LLC
Elucirem 485.1 mg/ml Intravenous Injection
NDC: 67684-4241
Labeler:
Guerbet LLC
Elucirem 485.1 mg/ml Intravenous Injection
NDC: 67684-4242
Labeler:
Guerbet LLC
Elucirem 485.1 mg/ml Intravenous Injection
NDC: 67684-4250
Labeler:
Guerbet LLC